Evidence map›Paper›PMID 41272160›Full record

ArticleScientific reports2025

Spatial variation in risk factors for anti-hepatitis E antibody titers in a population-based German study.

Andrea C Díaz, Till Ittermann, Matthias Nauck, Astrid Petersmann, Henry Völzke, Birgit Schauer

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrea C DíazDepartment SHIP-KEF, Institute of Community Medicine, University Medicine Greifswald, Greifswald, Germany. andrea.diaz@lih.lu.
Till IttermannDepartment SHIP-KEF, Institute of Community Medicine, University Medicine Greifswald, Greifswald, Germany.
Matthias NauckInstitute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
Astrid PetersmannInstitute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
Henry VölzkeDepartment SHIP-KEF, Institute of Community Medicine, University Medicine Greifswald, Greifswald, Germany.
Birgit SchauerDepartment SHIP-KEF, Institute of Community Medicine, University Medicine Greifswald, Greifswald, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transmission of hepatitis E virus (HEV) genotype 3 remains unclear. Up to date, it is predominantly considered a foodborne disease. However, there is growing evidence that other transmission pathways exist. The aim of this study was to analyze risk factors for anti-HEV IgG titers in the Study of Health in Pomerania, a population-based cohort located in Northeast Germany. We performed cross-sectional analyses using quantile and logistic regression. Spatial location was included as an interaction term to explore whether residential location of the participant acts as an effect modifier. The risk factors assessed were consumption frequency of meat, sausage, fish and raw vegetables, high-risk occupation and animal contact. The estimated seroprevalence of anti-HEV IgG was 27.3% (95% confidence interval [CI] 26.0%, 28.6%). Participants living in rural coastal areas had 14.5 U/ml higher antibody titers both for high meat (95% CI 3.9, 25.2; P = 0.008) and high sausage consumption (95% CI 4.1, 24.9; P = 0.006) in comparison with low consumption. In urban areas, participants who had contact with domestic carnivores had higher antibody titers (by 12.8 U/ml; 95% CI 0.3, 25.3; P = 0.046). Our results imply that risk factors of HEV exposure might differ among geographical regions. More research is needed to clarify the mechanisms underlying these findings.

Indexed as

Hepatitis AntibodiesHepatitis EHepatitis E virusAdultAgedAnimalsCross-Sectional StudiesFemaleGermanyHumansImmunoglobulin GMaleMiddle AgedRisk FactorsSeroepidemiologic StudiesYoung AdultHepatitis AntibodiesImmunoglobulin GCompanion animalsGermanyHepatitis ERisk factorsSerology

Identifiers

PMID41272160
PMCPMC12644998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.